Atea Pharmaceuticals Inc. (AVIR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Atea Pharmaceuticals Inc.

NASDAQ: AVIR · Real-Time Price · USD
2.92
-0.01 (-0.34%)
At close: Sep 29, 2025, 3:59 PM
2.92
0.00%
After-hours: Sep 29, 2025, 04:44 PM EDT

Atea Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
64.7M 143.82M 188.46M 764.38M
Short-Term Investments
390.02M 434.28M 458.25M n/a
Long-Term Investments
n/a n/a 198K 305K
Other Long-Term Assets
197K 1.4M 1.49M 161K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
7.63M 12.35M 14.21M n/a
Total Current Assets
462.36M 590.46M 660.92M 772.4M
Property-Plant & Equipment
2.12M 3.12M 4.09M 23K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.31M 4.51M 5.79M 489K
Total Assets
464.67M 594.97M 666.71M 772.89M
Account Payables
4.46M 4.25M 2.55M 4.53M
Deferred Revenue
n/a n/a n/a -197K
Short-Term Debt
800K 760K 721K 197K
Other Current Liabilities
6.64M 20.91M 7.93M 45.37M
Total Current Liabilities
18.6M 32.38M 18.48M 56.88M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
6.36M 5.76M 5.25M 5.93M
Total Long-Term Liabilities
7.2M 7.4M 7.66M 5.93M
Total Liabilities
25.8M 39.78M 26.14M 62.81M
Total Debt
1.64M 2.4M 3.12M 197K
Book Value
438.87M 555.19M 640.57M 710.08M
Book Value Per Share
5.21 6.66 7.69 8.57
Common Stock
84K 83K 83K 83K
Retained Earnings
-364.22M -195.84M -59.88M 56.03M
Comprehensive Income
233K 207K -684K n/a
Shareholders Equity
438.87M 555.19M 640.57M 710.08M
Total Investments
390.02M 434.28M 458.25M 305K